You are here

Our science / Clinical Trials / Find a Trial / NCT00731562

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

Back to Search Print Save as PDF Bookmark Trial

NCT00731562

Last updated on February 17, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
East Grand Forks, Minnesota, 56721 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pharmacokinetics, Bioavailability, Smoking Cessation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male or female adult smokers

- 18 to 55 years of age

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Sensitivity to varenicline

- Illegal drug use

- Pregnant or nursing females

NCT00731562
Pfizer
Completed
An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Pharmacokinetics
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
NCT00556998
All Genders
12+
Years
Multiple Sites
Smoking Cessation
Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients
NCT00794365
All Genders
Pharmacokinetics
A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers
NCT01181700
All Genders
21+
Years
Singapore,
Smoking Cessation
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
NCT00527150
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now